Tvardi Therapeutics, Inc. · NASDAQ:TVRD
Sporos Bioventures LLC reported a 8.95% stake in Tvardi Therapeutics, Inc. (Schedule 13G)
Event Apr 15, 2025 · Filed Aug 8, 2025
Sporos Bioventures LLC reported a 8.95% stake in Tvardi Therapeutics, Inc., 837,636 shares, as a passive investor on Apr 15, 2025. Filed Aug 8, 2025 (Schedule 13G).
- Stake
- 8.95%
- Shares
- 837,636
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Sporos Bioventures LLC | 8.95% | 837,636 |
Source
Related
- Tvardi Therapeutics, Inc.
- Sporos Bioventures LLC
- Tvardi Therapeutics, Inc. shareholders
- Schedule 13G/A · Ronald A. DePinho · Feb 17, 2026
- Schedule 13G/A · Ronald A. DePinho · Nov 14, 2025
- Schedule 13G · Slate Path Capital LP · Aug 14, 2025
- Schedule 13G/A · Samuel D. Tweardy · Aug 5, 2025
- Schedule 13G · Ronald A. DePinho · Jun 2, 2025